1. Patient reported outcome measures: use in medical product development to support labeling claims;FDA Draft Guidance for Industry,2006
2. Effect of rosiglitzone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial;The DREAM (Diabetes reduction Assessment with ramipril and rosiglitazone medication) Trial Investigators;Lancet,2006
3. Composite outcomes in randomized trials—greater precision but with greater uncertainty?;Freemantle;J Am Med Assoc,2003